175 related articles for article (PubMed ID: 8129644)
1. Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine.
Brewer GJ; Turkay A; Yuzbaziyan-Gurkan V
Arch Neurol; 1994 Mar; 51(3):304-5. PubMed ID: 8129644
[TBL] [Abstract][Full Text] [Related]
2. Wilson's disease. Development of neurological disease after beginning penicillamine therapy.
Glass JD; Reich SG; DeLong MR
Arch Neurol; 1990 May; 47(5):595-6. PubMed ID: 2334309
[TBL] [Abstract][Full Text] [Related]
3. Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation.
Porzio S; Iorio R; Vajro P; Pensati P; Vegnente A
Arch Neurol; 1997 Sep; 54(9):1166-8. PubMed ID: 9311362
[TBL] [Abstract][Full Text] [Related]
4. Wilson's disease: initial worsening of neurologic syndrome with penicillamine therapy.
Kher A; Bharucha BA; Kumta NB
Indian Pediatr; 1992 Jul; 29(7):927-9. PubMed ID: 1428152
[No Abstract] [Full Text] [Related]
5. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.
Brewer GJ; Terry CA; Aisen AM; Hill GM
Arch Neurol; 1987 May; 44(5):490-3. PubMed ID: 3579660
[TBL] [Abstract][Full Text] [Related]
6. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.
Brewer GJ; Dick RD; Johnson V; Wang Y; Yuzbasiyan-Gurkan V; Kluin K; Fink JK; Aisen A
Arch Neurol; 1994 Jun; 51(6):545-54. PubMed ID: 8198464
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
9. Penicillamine-related lichenoid dermatitis and utility of zinc acetate in a Wilson disease patient with hepatic presentation, anxiety and SPECT abnormalities.
Leggio L; Ferrulli A; Mirijello A; Abenavoli L; Di Giuda D; Funiciello S; Rotoli M; Gasbarrini G; Addolorato G
Int J Immunopathol Pharmacol; 2007; 20(1):185-90. PubMed ID: 17346443
[TBL] [Abstract][Full Text] [Related]
10. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
[No Abstract] [Full Text] [Related]
11. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
12. Treatment of the neurologic manifestations of Wilson's disease.
Scheinberg IH; Sternlieb I
Arch Neurol; 1995 Apr; 52(4):339-40. PubMed ID: 7710368
[No Abstract] [Full Text] [Related]
13. [Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Li M; Zhang YH; Qin J
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):119-22. PubMed ID: 14759316
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
15. [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
Hilz MJ; Druschky KF; Bauer J; Neundörfer B; Schuierer G
Dtsch Med Wochenschr; 1990 Jan; 115(3):93-7. PubMed ID: 2298126
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
Dingle J; Havener WH
Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410
[TBL] [Abstract][Full Text] [Related]
17. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
Veen C; van den Hamer CJ; de Leeuw PW
J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
[TBL] [Abstract][Full Text] [Related]
18. [Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].
Hiti H; Harpf H; Wutz W; Schmut O
Klin Monbl Augenheilkd; 1980 Feb; 176(2):235-8. PubMed ID: 7420971
[TBL] [Abstract][Full Text] [Related]
19. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
20. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
Degos R; Touraine R; Belaïch S; Revuz J
Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
